
This consensus document outlines the recommendations for the design of future trials related to refractory cardiogenic shock. This life-threatening syndrome is characterized by peripheral hypoperfusion and organ dysfunction due to primary cardiac disease. Current management strategies are based on experience, and outcomes remain poor. The document summarizes the output from the third Critical Care Clinical Trialists Workshop, where experts convened to discuss, debate, and reflect on approaches related to trials in refractory cardiogenic shock. The document focuses on current and future definitions of cardiogenic shock, recent and ongoing clinical trials, and future directions in light of the most recent literature.
Like
Save
Share